Parameter Utility Value Sources/Assumptions Age-specific utilities   [19] 30-39 years 0.940   40-49 years 0.930   50-59 years 0.920   60-69 years 0.910   70-79 years 0.910   80+ years 0.880   Health state–specific utilities     Healthy men: no PCa or BPH 1.000 Assumption BPH 0.963 [17] PCa: high-grade cancera 0.760 [18] PCa: low-grade cancera 0.840 [18] Death 0.000 Assumption Utility decrements/improvements     BPH symptom improvement due to use of dutasteride 0.018 [17] AUR 0.003 [17] BPH-related surgery 0.0005 [17] Ejaculatory dysfunction 0.007 [17] Impotence 0.029 [17] Hospitalization due to UTI 0.00058 [17] AUR = acute urinary retention; BPH = benign prostatic hyperplasia; PCa = prostate cancer; UTI = urinary tract infection. aUtilities for high-grade and low-grade tumors consider adverse events that may occur due to PCa treatment.

Table 1: Utility Weights and Utility Decrements for Calculating Quality-Adjusted Life-years.